These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26748694)

  • 41. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
    Jones K; Brennan KA; Colussi-Mas J; Schenk S
    Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A unique phenotype of 5-HT2C, agonist-induced GTPgamma35S binding, transferable to 5-HT2A and 5-HT2B, upon swapping intracellular regions.
    Alberts GL; Chio CL; Im WB; Slightom JL
    Br J Pharmacol; 2003 Feb; 138(3):427-34. PubMed ID: 12569067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT(2C) agonists for the treatment of metabolic disorders.
    Tye H; Mueller SG; Prestle J; Scheuerer S; Schindler M; Nosse B; Prevost N; Brown CJ; Heifetz A; Moeller C; Pedret-Dunn A; Whittaker M
    Bioorg Med Chem Lett; 2011 Jan; 21(1):34-7. PubMed ID: 21146986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists.
    Zuo Z; Chen G; Luo X; Puah C; Zhu W; Chen K; Jiang H
    Acta Biochim Biophys Sin (Shanghai); 2007 Jun; 39(6):413-22. PubMed ID: 17558446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Directly Observable Behavioral Effects of Lorcaserin in Rats.
    Serafine KM; Rice KC; France CP
    J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade.
    Fletcher PJ; Rizos Z; Noble K; Higgins GA
    Neuropharmacology; 2011 Sep; 61(3):468-77. PubMed ID: 21402085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel mannich bases, 5-arylimidazolidine-2,4-dione derivatives with dual 5-HT(1A) receptor and serotonin transporter affinity.
    Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Siwek A; Bojarski AJ; Bednarski M; Wróbel D; Wesołowska A
    Arch Pharm (Weinheim); 2013 Feb; 346(2):98-109. PubMed ID: 23288448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 5-HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment.
    Mongeau R; Martin CB; Chevarin C; Maldonado R; Hamon M; Robledo P; Lanfumey L
    J Neurochem; 2010 Oct; 115(2):438-49. PubMed ID: 20796171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
    Aloyo VJ; Berg KA; Spampinato U; Clarke WP; Harvey JA
    Pharmacol Ther; 2009 Feb; 121(2):160-73. PubMed ID: 19109993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, synthesis, and pharmacological characterization of N- and O-substituted 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol analogues: novel 5-HT(2A)/5-HT(2C) receptor agonists with pro-cognitive properties.
    Jensen AA; Plath N; Pedersen MH; Isberg V; Krall J; Wellendorph P; Stensbøl TB; Gloriam DE; Krogsgaard-Larsen P; Frølund B
    J Med Chem; 2013 Feb; 56(3):1211-27. PubMed ID: 23301527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.
    Andrés JI; Alcázar J; Alonso JM; Díaz A; Fernández J; Gil P; Iturrino L; Matesanz E; Meert TF; Megens A; Sipido VK
    Bioorg Med Chem Lett; 2002 Jan; 12(2):249-53. PubMed ID: 11755365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
    Bubar MJ; Cunningham KA
    Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential expression of 5-HT(2A) and 5-HT(2C) receptor mRNAs in mice prone, or resistant, to chronic high-fat diet-induced obesity.
    Huang XF; Han M; Storlien LH
    Brain Res Mol Brain Res; 2004 Aug; 127(1-2):39-47. PubMed ID: 15306119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased Incentive Motivation Following Knockout or Acute Blockade of the Serotonin Transporter: Role of the 5-HT2C Receptor.
    Browne CJ; Fletcher PJ
    Neuropsychopharmacology; 2016 Sep; 41(10):2566-76. PubMed ID: 27125304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel pyrimidoazepine analogs as serotonin 5-HT(2A) and 5-HT(2C) receptor ligands for the treatment of obesity.
    Yang HY; Tae J; Seo YW; Kim YJ; Im HY; Choi GD; Cho H; Park WK; Kwon OS; Cho YS; Ko M; Jang H; Lee J; Choi K; Kim CH; Lee J; Pae AN
    Eur J Med Chem; 2013 May; 63():558-69. PubMed ID: 23537943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
    Caliendo G; Fiorino F; Perissutti E; Severino B; Gessi S; Cattabriga E; Borea PA; Santagada V
    Eur J Med Chem; 2001; 36(11-12):873-86. PubMed ID: 11755230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression.
    Berg KA; Harvey JA; Spampinato U; Clarke WP
    Prog Brain Res; 2008; 172():287-305. PubMed ID: 18772038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ligand-directed serotonin 5-HT
    Felsing DE; Canal CE; Booth RG
    Eur J Pharmacol; 2019 Apr; 848():131-139. PubMed ID: 30689993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.